The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis?
Open accessThe DOI matches its Crossref record; 157 of the 157 references it cites were found in a registry or an index; 125 of the 161 sources its claims cite were checked for support.
Abstract
A strong genetic predisposition (60-80% of attributable risk) is present in Alzheimer's disease (AD). In view of this major genetic component, identification of the genetic risk factors has been a major objective in the AD field with the ultimate aim to better understand the pathological processes. In this review, we present how the genetic risk factors are involved in APP metabolism, β-amyloid peptide production, degradation, aggregation and toxicity, innate immunity, and Tau toxicity. In addition, on the basis of the new genetic landscape, resulting from the recent high-throughput genomic approaches and emerging neurobiological information, we propose an over-arching model in which the focal adhesion pathway and the related cell signalling are key elements in AD pathogenesis. The core of the focal adhesion pathway links the physiological functions of amyloid precursor protein and Tau with the pathophysiological processes they are involved in. This model includes several entry points, fitting with the different origins for the disease, and supports the notion that dysregulation of synaptic plasticity is a central node in AD. Notably, our interpretation of the latest data from genome wide association studies complements other hypotheses already developed in the AD field, i.e., amyloid cascade, cellular phase or propagation hypotheses. Genetically driven synaptic failure hypothesis will need to be further tested experimentally within the general AD framework.
Overview
CoChat Summary
TL;DR
This review synthesizes the post-GWAS genetic landscape of Alzheimer’s disease and argues that, beyond amyloid, many risk genes converge on the focal adhesion pathway and synaptic function. It proposes a “genetically driven synaptic failure” hypothesis in which APP, Tau, focal adhesion signaling, and Aβ toxicity form a circular, multi-entry model of AD pathogenesis.
Key findings
- AD has a strong genetic predisposition, estimated at 60–80% of attributable risk; APOE alone accounts for about 20%, and more than 45 genes/loci have been associated with AD risk, while monogenic forms represent less than 1% of cases.
- Post-GWAS genes support the amyloid cascade through APP metabolism/Aβ production (e.g., ADAM10, APH1B, BIN1, CD2AP, PICALM, ABCA7, SORL1), Aβ clearance (ApoE, CLU, PICALM, ABCA7, CR1, TREM2, CD33), and Aβ toxicity, with microglia implicated in clearance and plaque compaction.
- Many GWAS-defined genes also modulate Tau toxicity and belong to the focal adhesion pathway (e.g., CASS4, PTK2B, EPHA1, MADD, CD2AP, FERMT2, CELF1, TLN2; BIN1 interacts with FAK/F-actin), linking APP and Tau to synaptic dynamics.
- The authors propose an over-arching circular model in which focal adhesion/synaptic dysfunction is central, Aβ is sufficient but not necessary, and multiple entry points—APP/Tau dysfunction, Aβ toxicity, microglial dysfunction—can drive synaptic failure and cognitive decline.
Methods
- Narrative review; no primary experimental data are reported.
- Synthesizes AD genetics literature, including GWAS, next-generation sequencing, and post-GWAS functional studies in cellular and animal models (e.g., Drosophila, mouse, C. elegans), plus pathway and expression analyses.
- Main analysis integrates genetic risk loci with APP/Aβ biology, Tau pathology, microglial function, focal adhesion signaling, and synapse dynamics to propose the genetically driven synaptic failure model.
Limitations
- The authors state that GWAS-defined genes were initially characterized mainly in models built around the amyloid cascade hypothesis, creating bias, potential tautological reasoning, and a priori exclusion of other pathways; gene functions are often incompletely understood, and for some loci the responsible gene is difficult or impossible to assign due to multiple genes and complex linkage disequilibrium.
- The authors note that a large part of AD’s genetic component remains unknown and that the proposed synaptic failure hypothesis requires further experimental testing.
- Evident from the text: this is a review and interpretive synthesis, not a primary study; some supporting evidence is preliminary or unpublished (e.g., Kindlin-2 localization), and data linking many GWAS genes to synapses and Tau remain limited.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures
![Fig. 1 Circular diagram of AD genetic risk factors. The diagram shows (from outside to inside): (1) genomic loci in alphabetical order; (2) genes therein; (3) expression profiles of these genes in different cell types of the brain (grayscale); and (4) the pathways/processes/proteins to which these genes have been functionally linked (colour). Details of the functional studies supporting these linkages are available in Suppl. Table. Expression profiles were extracted from [155] (FPKM fragments per kilobase of transcript sequence per million mapped fragments). The circlize package of the R software (http://www.r-project.org/) was used to generate the diagram [38]](https://figures.cochat.ai/paper-figures/8e3b688d36ae43b0b02c9a6bde97207f/the-new-genetic-landscape-of-alzheimers-disease-from-amyloid-cascade-to-figure-1.jpg)




Verification
Claims the paper makes
86 Valid · 7 Not valid · 21 Not checked · 47 Own results and interpretations
Some cited sources support this claim and some don’t — read each source’s verdict below.
In the paper
“Accordingly, APP–integrin interaction is required for neurite outgrowth and contact guidance [123, 153].”
§ The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis? > Beyond Aβ peptides and the APP metabolism > APP’s role in synaptic function and AD-related synaptic dysfunction
What the sources say
- Disputedcites [123] Sosa LJ, Bergman J, Estrada-Bernal A, Glorioso TJ, Kittelson JM, Pfenninger KH (2013) Amyloid precursor protein is an autonomous growth cone adhesion molecule engaged in contact guidance. PLoS One 8:e64521. https://doi.org/10.1371/journal.pone.0064521 sourceExperimental — accuracy not yet measured
In the Discussion section “Determining APP-Mediated Adhesion” (page unavailable), the paper says APP-mediated adhesion alone can sustain neurite outgrowth and that APP–integrin complexes are not necessary for adhesion; it says their functional role remains unknown. The Results section “APP Influences Axonal Contact Guidance” reports effects of APP expression and integrin knock-down on substrate choice, not a requirement for their interaction. (LLM, conf=0.88)
Checked by a reasoning model — may be wrong.
- Partly supportedcites [153] Young-Pearse TL, Chen AC, Chang R, Marquez C, Selkoe DJ (2008) Secreted APP regulates the function of full-length APP in neurite outgrowth through interaction with integrin beta1. Neural Dev 3:15. https://doi.org/10.1186/1749-8104-3-15 sourceExperimental — accuracy not yet measured
The Results show that APP interacts with integrin β1 and that blocking integrin β1 abolishes the neurite-outgrowth increase seen in APP-knockout or APPs-α-treated neurons. They do not establish that APP–integrin interaction is required for neurite outgrowth generally: the blocking antibody had no significant effect on neurite length in wild-type neurons. Our copy does not report a contact-guidance result (searched: contact guidance). (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Disputed
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Together, these genetic analyses have pointed out more than 45 genes/loci associated with the risk of developing AD even if it is estimated that a large part of the genetic component of AD is still unknown [103].”
§ The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis? > Genetic landscape of AD
What the sources say
- Partly supportedcites [103] Ridge PG, Hoyt KB, Boehme K, Mukherjee S, Crane PK, Haines JL et al (2016) Assessment of the genetic variance of late-onset Alzheimer’s disease. Neurobiol Aging 41:200.e13–200.e20. https://doi.org/10.1016/j.neurobiolaging.2016.02.024 sourceExperimental — accuracy not yet measured
The Introduction reports more than 20 distinct AD-associated loci and additional rare variants in several genes, but does not establish the claimed count of more than 45 genes or loci. The Conclusions state that 69% of genetic variance remains unexplained, supporting the citing sentence’s separate point about the unknown genetic component. No page numbers are available in our copy. (LLM, conf=0.86)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“However, despite these effects on Aβ production in vitro, deleting a single BIN1 or CD2AP allele did not modify amyloid deposition in mouse models of AD [2, 87].”
§ The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis? > The post-GWAS era and the amyloid cascade hypothesis > APP metabolism and Aβ peptide production
What the sources say
- Supportedcites [2] Andrew RJ, De Rossi P, Nguyen P, Kowalski HR, Recupero AJ, Guerbette T et al (2019) Reduction of the expression of the late-onset Alzheimer’s disease (AD) risk-factor BIN1 does not affect amyloid pathology in an AD mouse model. J Biol Chem 294:4477–4487. https://doi.org/10.1074/jbc.ra118.006379 source
The Discussion reports that deletion of a single Bin1 allele reduced BIN1 protein by 50% and did not alter cerebral Aβ deposition in an AD mouse model. The CD2AP finding is not attributed specifically to this BIN1 paper in the sentence with two citations. (LLM, conf=0.93)
- Supportedcites [87] Liao F, Jiang H, Srivatsan S, Xiao Q, Lefton KB, Yamada K et al (2015) Effects of CD2-associated protein deficiency on amyloid-β in neuroblastoma cells and in an APP transgenic mouse model. Mol Neurodegener 10:12. https://doi.org/10.1186/s13024-015-0006-y source
The Results and discussion section (page not supplied) reports that PS1APP mice with one CD2AP allele had no difference in cortical Aβ plaque load at 7 months. This supports the CD2AP part of the sentence; the separate BIN1 citation is not assessed here. (LLM, conf=0.93)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“since the seminal GWAS papers published in 2009 [47, 83], more than 30 loci of interest have been identified to be associated with AD risk (Suppl. Table) [50, 59, 67, 76, 84, 97, 116, 120].”
§ The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis? > Genetic landscape of AD
What the sources say
- Supportedcites [47] Harold D, Abraham R, Hollingworth P, Sims R, Gerrish A, Hamshere ML et al (2009) Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer’s disease. Nat Genet 41:1088–1093. https://doi.org/10.1038/ng.440 source
The cited work is one of the 2009 GWAS papers identified in the sentence. Its Abstract reports a genome-wide association study that found AD-risk associations at CLU and PICALM. The claim that more than 30 loci were identified subsequently is attached to the sentence’s later citations, not to this paper. (LLM, conf=0.91)
- Supportedcites [83] Lambert J-C, Heath S, Even G, Campion D, Sleegers K, Hiltunen M et al (2009) Genome-wide association study identifies variants at CLU and CR1 associated with Alzheimer’s disease. Nat Genet 41:1094–1099. https://doi.org/10.1038/ng.439 source
The citation to this source is attached to “the seminal GWAS papers published in 2009,” not to the later count of more than 30 loci, which has separate citations. The paper’s Abstract describes its Alzheimer’s disease GWAS and reports associations at CLU and PICALM, so it supports its identification as a 2009 GWAS paper. (LLM, conf=0.93)
- Partly supportedcites [50] Hollingworth P, Harold D, Sims R, Gerrish A, Lambert J-C, Carrasquillo MM et al (2011) Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer’s disease. Nat Genet 43:429–435. https://doi.org/10.1038/ng.803 sourceExperimental — accuracy not yet measured
The Abstract reports five novel AD susceptibility genes, supporting this paper’s inclusion among studies identifying risk loci after the 2009 GWAS papers. It does not establish the sentence’s aggregate claim that more than 30 loci had been identified; that total is attributed to a group of citations, not demonstrated by this paper alone. (LLM, conf=0.88)
- Supportedcites [59] Jansen IE, Savage JE, Watanabe K, Bryois J, Williams DM, Steinberg S et al (2019) Genome-wide meta-analysis identifies new loci and functional pathways influencing Alzheimer’s disease risk. Nat Genet 51(3):404–413. https://doi.org/10.1038/s41588-018-0311-9 source
The Results (Genome-wide meta-analysis for AD status; page unavailable) report 29 associated loci, including 13 not identified in Lambert et al.’s earlier set of 20 regions. Together, those findings support more than 30 loci identified as being of interest for AD risk, although the paper notes that some earlier associations were not replicated. (LLM, conf=0.85)
- Partly supportedcites [67] Jun G, Ibrahim-Verbaas CA, Vronskaya M, Lambert J-C, Chung J, Naj AC et al (2015) A novel Alzheimer disease locus located near the gene encoding Tau protein. Mol Psychiatry. https://doi.org/10.1038/mp.2015.23 sourceExperimental — accuracy not yet measured
The Results report a newly identified genome-wide significant AD risk locus near MAPT, so this paper supports one example among the cited discoveries. It does not state that more than 30 loci had been identified since the 2009 GWAS papers; the count is not supported by this source alone. (LLM, conf=0.84)
- Partly supportedcites [76] Kunkle BW, Grenier-Boley B, Sims R, Bis JC, Damotte V, Naj AC et al (2019) Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, Tau, immunity and lipid processing. Nat Genet 51:414–430. https://doi.org/10.1038/s41588-019-0358-2 sourceExperimental — accuracy not yet measured
The Results (Meta-analysis of Alzheimer’s disease GWAS; page unavailable) report previously known associations and identify new Alzheimer’s disease risk loci. The paper supports the claim that loci continued to be identified after the 2009 GWAS papers, but its discussion of 24 associated loci does not establish the cited sentence’s total of more than 30. (LLM, conf=0.84)
- Partly supportedcites [84] Lambert JC, Ibrahim-Verbaas CA, Harold D, Naj AC, Sims R, Bellenguez C et al (2013) Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer’s disease. Nat Genet 45:1452–1458. https://doi.org/10.1038/ng.2802 sourceExperimental — accuracy not yet measured
The paper reports 19 loci reaching genome-wide significance in the combined analysis, in addition to APOE (Abstract; page unavailable). It also reports 13 further loci with only suggestive evidence of association (Abstract; page unavailable). Together these exceed 30 loci of interest, but the source does not establish all of them as associated with Alzheimer’s disease risk. (LLM, conf=0.84)
- Partly supportedcites [97] Naj AC, Jun G, Beecham GW, Wang L-S, Vardarajan BN, Buros J et al (2011) Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer’s disease. Nat Genet 43:436–441. https://doi.org/10.1038/ng.801 sourceExperimental — accuracy not yet measured
The paper’s Abstract reports genome-wide significant associations at four late-onset Alzheimer’s disease loci, supporting this source’s contribution to the citing sentence’s list. It says there were ten known susceptibility loci at the time, however, so this paper does not establish the cumulative claim of more than 30 loci since 2009. (LLM, conf=0.86)
- Partly supportedcites [116] Seshadri S, Fitzpatrick AL, Ikram MA, DeStefano AL, Gudnason V, Boada M et al (2010) Genome-wide analysis of genetic loci associated with Alzheimer disease. JAMA 303:1832–1840. https://doi.org/10.1001/jama.2010.574 sourceExperimental — accuracy not yet measured
The Results section reports several AD-associated loci, including two novel loci on chromosomes 2 and 19, so this paper supports the citation as an example of loci identified after the 2009 GWAS papers. It does not support the sentence’s aggregate count of more than 30 loci. (LLM, conf=0.88)
- Partly supportedcites [120] Sims R, van der Lee SJ, Naj AC, Bellenguez C, Badarinarayan N, Jakobsdottir J et al (2017) Rare coding variants in PLCG2, ABI3, and TREM2 implicate microglial-mediated innate immunity in Alzheimer’s disease. Nat Genet 49:1373–1384. https://doi.org/10.1038/ng.3916 sourceExperimental — accuracy not yet measured
The paper states that nearly 30 late-onset AD susceptibility loci were known and reports additional associated variants in PLCG2, ABI3 and TREM2 (opening text and Abstract; page not specified). It does not establish the citing sentence’s count of more than 30 loci. (LLM, conf=0.88)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“More recently, PICALM has been described in vitro and in vivo to participate to Aβ transcytosis and clearance at the BBB through clathrin-dependent internalisation of Aβ after its binding to the LDLR-related protein-1 [157].”
§ The new genetic landscape of Alzheimer’s disease: from amyloid cascade to genetically driven synaptic failure hypothesis? > The post-GWAS era and the amyloid cascade hypothesis > Aβ peptide degradation/clearance
What the sources say
- Supportedcites [157] Zhao Z, Sagare AP, Ma Q, Halliday MR, Kong P, Kisler K et al (2015) Central role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance. Nat Neurosci 18:978–987. https://doi.org/10.1038/nn.4025 source
The Results section on PICALM/clathrin-dependent endocytosis states that Aβ binding to LRP1 initiates endocytosis of the Aβ–LRP1 complex. The Introduction identifies endothelial PICALM as central to Aβ clearance and transcytosis across the BBB, and the Results report transendothelial transport of the internalized complex. (LLM, conf=0.94)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
100 more claims · 60 with their cited sources checked
Create a free account to see all 161 claims and to verify the 3 references still open.
- It may state two separate claims as one. 43
- Probably not a substantial claim. 17
- Not yet classified. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“emphasizing that ADD results from complex crosstalk between different cell types in the brain23,40.”
From New insights into the genetic etiology of Alzheimer’s disease and related dementias (2022) · cites this paper as [23]
Citations
Cites
The Amyloid Hypothesis of Alzheimer’s Disease: Progress and Problems on the Road to Therapeutics
Hardy, J., & Selkoe, D. J. (2002) · Science · doi:10.1126/science.1072994 · Cited by 13,864
Meta-Analysis of 74,046 Individuals Identifies 11 New Susceptibility Loci for Alzheimer’s Disease
(EADI), E. A. D. I., Lambert, J.-C., (GERAD), G. A. E. R. I. A. D., Alzheimer's Disease Genetic Consortium (ADGC), (CHARGE), C. F. H. A. A. R. I. G. E., Ibrahim-Verbaas, C. A., Harold, D., Naj, A. C., Sims, R., Bellenguez, C., et al. (2013) · Nature Genetics · doi:10.1038/ng.2802 · Cited by 4,336 · cited 10×
“CD2AP [95, 108, 138, 144, 184] CD2AP CD2 associated protein, scaffolding protein involved in the regulation of membrane receptor endocytosis and signaling, actin cytoskeleton organization, endosomal vesicular trafficking, cell adhesion and cytokinesis [47, 61, 83, 116, 137, 157, 291] -its loss-of-function raises Aβ ge…”
BackgroundInfluentialSelf-citationcirclize implements and enhances circular visualization in R
Gu, Z., Gu, L., Eils, R., Schlesner, M., & Brors, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu393 · Cited by 4,246
Complement and microglia mediate early synapse loss in Alzheimer mouse models
Hong, S., Beja-Glasser, V. F., Nfonoyim, B. M., Frouin, A., Li, S., Ramakrishnan, S., Merry, K. M., Shi, Q., Rosenthal, A., Barres, B. A., et al. (2016) · Science · doi:10.1126/science.aad8373 · Cited by 3,343 · cited 1×
“It is also suspected that perturbations in homeostatic microglia functions at synapses may lead to early synapse loss in an Aβ-dependent or potentially independent manner [52, 93].”
BackgroundHarold, D., Abraham, R., Hollingworth, P., Sims, R., Gerrish, A., Hamshere, M. L., Pahwa, J. S., Moskvina, V., Dowzell, K., Williams, A., et al. (2009) · Nature Genetics · doi:10.1038/ng.440 · Cited by 3,326
TREM2 Variants in Alzheimer's Disease
Guerreiro, R., Wojtas, A., Bras, J., Carrasquillo, M., Rogaeva, E., Majounie, E., Cruchaga, C., Sassi, C., Kauwe, J. S. K., Younkin, S., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211851 · Cited by 3,020 · cited 1×
“1); and (4) a major genetic discovery indicated that non-synonymous variants in TREM2, ABI3 and PLCγ2 were associated with AD risk [40, 65, 120].”
BackgroundSelf-citationAlzheimer Disease Genetics Consortium (ADGC), Kunkle, B. W., The European Alzheimer’s Disease Initiative (EADI), Cohorts for Heart and Aging Research in Genomic Epidemiology Consortium (CHARGE), Genetic and Environmental Risk in AD/Defining Genetic, P. A. E. R. F. A. D. C. (., Grenier-Boley, B., Sims, R., Bis, J. C., Damotte, V., Naj, A. C., et al. (2019) · Nature Genetics · doi:10.1038/s41588-019-0358-2 · Cited by 2,946 · cited 1×
“Very recent GWASs have strengthened the importance of APP metabolism by directly pointing out two of its main actors as AD genetic risk factors: ADAM10, which carries out the main α-secretase activity in the brain, and APH1B, which is part of the γ-secretase complex [59, 76].”
BackgroundVariant of TREM2 Associated with the Risk of Alzheimer's Disease
Jonsson, T., Stefansson, H., Steinberg, S., Jonsdottir, I., Jonsson, P. V., Snaedal, J., Bjornsson, S., Huttenlocher, J., Levey, A. I., Lah, J. J., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1211103 · Cited by 2,558 · cited 2×
“1); and (4) a major genetic discovery indicated that non-synonymous variants in TREM2, ABI3 and PLCγ2 were associated with AD risk [40, 65, 120].”
BackgroundZhang, Y., Sloan, S. A., Clarke, L. E., Caneda, C., Plaza, C. A., Blumenthal, P. D., Vogel, H., Steinberg, G. K., Edwards, M. S. B., Li, G., et al. (2016) · Neuron · doi:10.1016/j.neuron.2015.11.013 · Cited by 2,295 · cited 1×
“Expression profiles were extracted from [155] (FPKM fragments per kilobase of transcript sequence per million mapped fragments).”
Jansen, I. E., Savage, J. E., Watanabe, K., Bryois, J., Williams, D. M., Steinberg, S., Sealock, J., Karlsson, I. K., Hägg, S., Athanasiu, L., et al. (2019) · Nature Genetics · doi:10.1038/s41588-018-0311-9 · Cited by 2,277 · cited 2×
“Very recent GWASs have strengthened the importance of APP metabolism by directly pointing out two of its main actors as AD genetic risk factors: ADAM10, which carries out the main α-secretase activity in the brain, and APH1B, which is part of the γ-secretase complex [59, 76].”
BackgroundGenome-wide association study identifies variants at CLU and CR1 associated with Alzheimer's disease
the European Alzheimer's Disease Initiative Investigators, Lambert, J.-C., Heath, S., Even, G., Campion, D., Sleegers, K., Hiltunen, M., Combarros, O., Zelenika, D., Bullido, M. J., et al. (2009) · Nature Genetics · doi:10.1038/ng.439 · Cited by 2,234
Self-citationInitiative, T. A. D. N., Hollingworth, P., CHARGE consortium, EADI1 consortium, Harold, D., Sims, R., Gerrish, A., Lambert, J.-C., Carrasquillo, M. M., Abraham, R., et al. (2011) · Nature Genetics · doi:10.1038/ng.803 · Cited by 1,997 · cited 16×
“CD2AP [95, 108, 138, 144, 184] CD2AP CD2 associated protein, scaffolding protein involved in the regulation of membrane receptor endocytosis and signaling, actin cytoskeleton organization, endosomal vesicular trafficking, cell adhesion and cytokinesis [47, 61, 83, 116, 137, 157, 291] -its loss-of-function raises Aβ ge…”
BackgroundInfluentialSelf-citationThe Cellular Phase of Alzheimer’s Disease
De Strooper, B., & Karran, E. (2016) · Cell · doi:10.1016/j.cell.2015.12.056 · Cited by 1,990 · cited 1×
“APOE [46] APOE apolipoprotein E maintains the structure of specific lipoprotein particles and directs lipoproteins to specific cell surface receptors 3 alleles/isoforms, ε2, ε3, ε4, the first and the last being protective and deleterious respectively for Alzheimer's disease - binding to Aβ - role in Aβ production - ro…”
BackgroundMicroglia in Alzheimer’s disease
Hansen, D. V., Hanson, J. E., & Sheng, M. (2018) · Journal of Cell Biology · doi:10.1083/jcb.201709069 · Cited by 1,935 · cited 2×
“Indeed, several genomic analyses suggest the involvement of microglia in AD: (1) the first reports on pathway enrichment analyses indicated the involvement of innate immunity in AD [81]; (2) as previously mentioned, these analyses highlighted the regulation of endocytosis (which is essential for phagocytosis) [64, 81]…”
BackgroundNaj, A. C., Jun, G., Beecham, G. W., Wang, L.-S., Vardarajan, B. N., Buros, J., Gallins, P. J., Buxbaum, J. D., Jarvik, G. P., Crane, P. K., et al. (2011) · Nature Genetics · doi:10.1038/ng.801 · Cited by 1,901 · cited 7×
“CD2AP [95, 108, 138, 144, 184] CD2AP CD2 associated protein, scaffolding protein involved in the regulation of membrane receptor endocytosis and signaling, actin cytoskeleton organization, endosomal vesicular trafficking, cell adhesion and cytokinesis [47, 61, 83, 116, 137, 157, 291] -its loss-of-function raises Aβ ge…”
BackgroundInfluentialReducing Endogenous Tau Ameliorates Amyloid ß-Induced Deficits in an Alzheimer's Disease Mouse Model
Roberson, E. D., Scearce-Levie, K., Palop, J. J., Yan, F., Cheng, I. H., Wu, T., Gerstein, H., Yu, G.-Q., & Mucke, L. (2007) · Science · doi:10.1126/science.1141736 · Cited by 1,892 · cited 1×
“Moreover, Tau–Fyn interaction in synapses has been shown to be required to induce pathology in mice over-expressing APP, where reduced Tau levels decrease excitotoxicity and reduced Fyn levels prevent Aβ toxicity [104].”
BackgroundDendritic Function of Tau Mediates Amyloid-β Toxicity in Alzheimer's Disease Mouse Models
Ittner, L. M., Ke, Y. D., Delerue, F., Bi, M., Gladbach, A., van Eersel, J., Wölfing, H., Chieng, B. C., Christie, M. J., Napier, I. A., et al. (2010) · Cell · doi:10.1016/j.cell.2010.06.036 · Cited by 1,821
Transmission and spreading of tauopathy in transgenic mouse brain
Clavaguera, F., Bolmont, T., Crowther, R. A., Abramowski, D., Frank, S., Probst, A., Fraser, G., Stalder, A. K., Beibel, M., Staufenbiel, M., et al. (2009) · Nature Cell Biology · doi:10.1038/ncb1901 · Cited by 1,803
Role of Genes and Environments for Explaining Alzheimer Disease
Gatz, M., Reynolds, C. A., Fratiglioni, L., Johansson, B., Mortimer, J. A., Berg, S., Fiske, A., & Pedersen, N. L. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.168 · Cited by 1,798
The role of apolipoprotein E in Alzheimer's disease
Kim, J., Basak, J. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.06.026 · Cited by 1,661 · cited 2×
“In this view, consistent evidence strongly suggest that ApoE regulates extracellular Aβ clearance in the brain [71].”
BackgroundGenome-wide Analysis of Genetic Loci Associated With Alzheimer Disease
Seshadri, S. (2010) · JAMA · doi:10.1001/jama.2010.574 · Cited by 1,219
The Intersection of Amyloid Beta and Tau at Synapses in Alzheimer’s Disease
Spires-Jones, T. L., & Hyman, B. T. (2014) · Neuron · doi:10.1016/j.neuron.2014.05.004 · Cited by 1,201
Hoover, B. R., Reed, M. N., Su, J., Penrod, R. D., Kotilinek, L. A., Grant, M. K., Pitstick, R., Carlson, G. A., Lanier, L. M., Yuan, L.-L., et al. (2010) · Neuron · doi:10.1016/j.neuron.2010.11.030 · Cited by 1,118
ARUK Consortium, Sims, R., GERAD/PERADES, C., van der Lee, S. J., Naj, A. C., Bellenguez, C., Badarinarayan, N., Jakobsdottir, J., Kunkle, B. W., Boland, A., et al. (2017) · Nature Genetics · doi:10.1038/ng.3916 · Cited by 1,012
Alzheimer’s Disease Risk Gene CD33 Inhibits Microglial Uptake of Amyloid Beta
Griciuc, A., Serrano-Pozo, A., Parrado, A. R., Lesinski, A. N., Asselin, C. N., Mullin, K., Hooli, B., Choi, S. H., Hyman, B. T., & Tanzi, R. E. (2013) · Neuron · doi:10.1016/j.neuron.2013.04.014 · Cited by 1,004
Yeh, F. L., Wang, Y., Tom, I., Gonzalez, L. C., & Sheng, M. (2016) · Neuron · doi:10.1016/j.neuron.2016.06.015 · Cited by 943
TREM2-mediated early microglial response limits diffusion and toxicity of amyloid plaques
Wang, Y., Ulland, T. K., Ulrich, J. D., Song, W., Tzaferis, J. A., Hole, J. T., Yuan, P., Mahan, T. E., Shi, Y., Gilfillan, S., et al. (2016) · Journal of Experimental Medicine · doi:10.1084/jem.20151948 · Cited by 840 · cited 1×
“In AD-like transgenic mice models, TREM2 knockdown is associated with increased amyloid loads [60, 141].”
BackgroundLack of apolipoprotein E dramatically reduces amyloid β-peptide deposition
Bales, K. R., Verina, T., Dodel, R. C., Du, Y., Altstiel, L., Bender, M., Hyslop, P., Johnstone, E. M., Little, S. P., Cummins, D. J., et al. (1997) · Nature Genetics · doi:10.1038/ng1197-263 · Cited by 830
Yuan, P., Condello, C., Keene, C. D., Wang, Y., Bird, T. D., Paul, S. M., Luo, W., Colonna, M., Baddeley, D., & Grutzendler, J. (2016) · Neuron · doi:10.1016/j.neuron.2016.05.003 · Cited by 817
Actin in dendritic spines: connecting dynamics to function
Hotulainen, P., & Hoogenraad, C. C. (2010) · Journal of Cell Biology · doi:10.1083/jcb.201003008 · Cited by 815 · cited 1×
“The integrin-dependent FA pathway has been subsequently involved in synaptic density and activity through spine shape, stability and signalling machinery therein [54].”
BackgroundTau is essential to β-amyloid-induced neurotoxicity
Rapoport, M., Dawson, H. N., Binder, L. I., Vitek, M. P., & Ferreira, A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.092136199 · Cited by 807
Apolipoprotein E and Apolipoprotein E Receptors: Normal Biology and Roles in Alzheimer Disease
Holtzman, D. M., Herz, J., & Bu, G. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006312 · Cited by 782 · cited 1×
“Beyond ApoE, which has been reported as a potential modulator of Aβ toxicity (see reviews [51, 131]), little has been done to determine whether other GWAS-defined genes are involved in Aβ toxicity.”
BackgroundapoE isoform–specific disruption of amyloid β peptide clearance from mouse brain
Deane, R., Sagare, A., Hamm, K., Parisi, M., Lane, S., Finn, M. B., Holtzman, D. M., & Zlokovic, B. V. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36663 · Cited by 771 · cited 1×
“In animal models, Aβ–ApoE2 and Aβ–ApoE3 complexes are cleared by the blood brain barrier (BBB) at a substantially higher rate than Aβ–ApoE4 complexes [23].”
BackgroundAPOE and Alzheimer disease: a major gene with semi-dominant inheritance
Genin, E., Hannequin, D., Wallon, D., Sleegers, K., Hiltunen, M., Combarros, O., Bullido, M. J., Engelborghs, S., De Deyn, P., Berr, C., et al. (2011) · Molecular Psychiatry · doi:10.1038/mp.2011.52 · Cited by 714 · cited 1×
“APOE is estimated to account for 20% of the AD attributable risk, and the APOE-associated risk is similar to those identified for major genes in other Mendelian diseases, such as BRCA1 in breast cancer [31].”
BackgroundSelf-citationAndersen, O. M., Reiche, J., Schmidt, V., Gotthardt, M., Spoelgen, R., Behlke, J., von Arnim, C. A. F., Breiderhoff, T., Jansen, P., Wu, X., et al. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0503689102 · Cited by 655
Not just amyloid: physiological functions of the amyloid precursor protein family
Müller, U. C., Deller, T., & Korte, M. (2017) · Nature Reviews Neuroscience · doi:10.1038/nrn.2017.29 · Cited by 634 · cited 1×
“A growing body of evidence also suggests a physiological role for APP in synaptic functions [96], potentially through cell adhesion.”
BackgroundPathogenic protein seeding in Alzheimer disease and other neurodegenerative disorders
Jucker, M., & Walker, L. C. (2011) · Annals of Neurology · doi:10.1002/ana.22615 · Cited by 622 · cited 1×
“A synapse-centred hypothesis also does not preclude the spreading hypothesis [34, 66], which could be either a downstream pathological event or a potential trigger”
BackgroundInterplay between innate immunity and Alzheimer disease: APOE and TREM2 in the spotlight
Shi, Y., & Holtzman, D. M. (2018) · Nature Reviews Immunology · doi:10.1038/s41577-018-0051-1 · Cited by 595
Apolipoprotein E Is a Ligand for Triggering Receptor Expressed on Myeloid Cells 2 (TREM2)
Atagi, Y., Liu, C.-C., Painter, M. M., Chen, X.-F., Verbeeck, C., Zheng, H., Li, X., Rademakers, R., Kang, S. S., Xu, H., et al. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.679043 · Cited by 587 · cited 1×
“Importantly, microglial uptake of Aβ is more efficient when TREM2 forms complexes with lipoproteins such as ApoE or CLU [132, 150] and TREM2–lipoprotein interaction is impaired by R47H and R62H mutations [3, 4].”
BackgroundBales, K. R., Verina, T., Cummins, D. J., Du, Y., Dodel, R. C., Saura, J., Fishman, C. E., DeLong, C. A., Piccardo, P., Petegnief, V., et al. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.26.15233 · Cited by 486
Morris, M., Knudsen, G. M., Maeda, S., Trinidad, J. C., Ioanoviciu, A., Burlingame, A. L., & Mucke, L. (2015) · Nature Neuroscience · doi:10.1038/nn.4067 · Cited by 472
ApoE and Clusterin Cooperatively Suppress Aβ Levels and Deposition
DeMattos, R. B., Cirrito, J. R., Parsadanian, M., May, P. C., O'Dell, M. A., Taylor, J. W., Harmony, J. A. K., Aronow, B. J., Bales, K. R., Paul, S. M., et al. (2004) · Neuron · doi:10.1016/s0896-6273(03)00850-x · Cited by 459
Disease Progression-Dependent Effects of TREM2 Deficiency in a Mouse Model of Alzheimer's Disease
Jay, T. R., Hirsch, A. M., Broihier, M. L., Miller, C. M., Neilson, L. E., Ransohoff, R. M., Lamb, B. T., & Landreth, G. E. (2017) · The Journal of Neuroscience · doi:10.1523/jneurosci.2110-16.2016 · Cited by 457
Synaptic Impairment in Alzheimer’s Disease: A Dysregulated Symphony
Forner, S., Baglietto-Vargas, D., Martini, A. C., Trujillo-Estrada, L., & LaFerla, F. M. (2017) · Trends in Neurosciences · doi:10.1016/j.tins.2017.04.002 · Cited by 430
A common haplotype lowers PU.1 expression in myeloid cells and delays onset of Alzheimer's disease
The International Genomics of Alzheimer's Project, Huang, K.-L., Initiative, T. A. D. N., Marcora, E., Pimenova, A. A., Di Narzo, A. F., Kapoor, M., Jin, S. C., Harari, O., Bertelsen, S., et al. (2017) · Nature Neuroscience · doi:10.1038/nn.4587 · Cited by 423
Self-citationCentral role for PICALM in amyloid-β blood-brain barrier transcytosis and clearance
Zhao, Z., Sagare, A. P., Ma, Q., Halliday, M. R., Kong, P., Kisler, K., Winkler, E. A., Ramanathan, A., Kanekiyo, T., Bu, G., et al. (2015) · Nature Neuroscience · doi:10.1038/nn.4025 · Cited by 410
Increased expression of BIN1 mediates Alzheimer genetic risk by modulating tau pathology
GERAD consortium, Chapuis, J., Hansmannel, F., Gistelinck, M., Mounier, A., Van Cauwenberghe, C., Kolen, K. V., Geller, F., Sottejeau, Y., Harold, D., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2013.1 · Cited by 407 · cited 2×
“Loss- and gain-of-function of the Drosophila ortholog of BIN1 modified the rough eye phenotype induced by human Tau expression [18].”
BackgroundSelf-citationMairet-Coello, G., Courchet, J., Pieraut, S., Courchet, V., Maximov, A., & Polleux, F. (2013) · Neuron · doi:10.1016/j.neuron.2013.02.003 · Cited by 351
Loss-of-function variants in ABCA7 confer risk of Alzheimer's disease
DemGene, Steinberg, S., Stefansson, H., Jonsson, T., Johannsdottir, H., Ingason, A., Helgason, H., Sulem, P., Magnusson, O. T., Gudjonsson, S. A., et al. (2015) · Nature Genetics · doi:10.1038/ng.3246 · Cited by 324 · cited 1×
“In addition, these methodologies demonstrated that both SORL1 and ABCA7 genes— already detected by GWAS—carried numerous loss-offunction variants leading to strong increases in AD risk [9, 98, 128].”
Fyn inhibition rescues established memory and synapse loss in Alzheimer mice
Kaufman, A. C., Salazar, S. V., Haas, L. T., Yang, J., Kostylev, M. A., Jeng, A. T., Robinson, S. A., Gunther, E. C., van Dyck, C. H., Nygaard, H. B., et al. (2015) · Annals of Neurology · doi:10.1002/ana.24394 · Cited by 314 · cited 1×
“This reciprocal regulation is further supported by the observation that Aβ-induced Fyn signalling is associated with downstream Pyk2 phosphorylation [68].”
BackgroundKim, J., Castellano, J. M., Jiang, H., Basak, J. M., Parsadanian, M., Pham, V., Mason, S. M., Paul, S. M., & Holtzman, D. M. (2009) · Neuron · doi:10.1016/j.neuron.2009.11.013 · Cited by 308 · cited 1×
“LDLR overexpression dramatically enhanced Aβ clearance from the brain’s extracellular fluid and reduced Aβ aggregation [72].”
BackgroundMicrotubule-associated protein tau is essential for long-term depression in the hippocampus
Kimura, T., Whitcomb, D. J., Jo, J., Regan, P., Piers, T., Heo, S., Brown, C., Hashikawa, T., Murayama, M., Seok, H., et al. (2014) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2013.0144 · Cited by 307
Pottier, C., Hannequin, D., Coutant, S., Rovelet-Lecrux, A., Wallon, D., Rousseau, S., Legallic, S., Paquet, C., Bombois, S., Pariente, J., et al. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.15 · Cited by 305
Self-citationThe Triggering Receptor Expressed on Myeloid Cells 2 Binds Apolipoprotein E
Bailey, C. C., DeVaux, L. B., & Farzan, M. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.677286 · Cited by 303 · cited 1×
“Importantly, microglial uptake of Aβ is more efficient when TREM2 forms complexes with lipoproteins such as ApoE or CLU [132, 150] and TREM2–lipoprotein interaction is impaired by R47H and R62H mutations [3, 4].”
BackgroundA novel Alzheimer disease locus located near the gene encoding tau protein
Jun, G., Ibrahim-Verbaas, C. A., Vronskaya, M., Lambert, J.-C., Chung, J., Naj, A. C., Kunkle, B. W., Wang, L.-S., Bis, J. C., Bellenguez, C., et al. (2016) · Molecular Psychiatry · doi:10.1038/mp.2015.23 · Cited by 297 · cited 1×
“MAPT [118] MAPT microtubule associated protein tau Composing one of AD hallmarks too huge to be reviewed here too huge to be reviewed here too huge to be reviewed here”
BackgroundSelf-citationApolipoproteins in human cerebrospinal fluid.
Roheim, P. S., Carey, M., Forte, T., & Vega, G. L. (1979) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.76.9.4646 · Cited by 282 · cited 9×
“Importantly, microglial uptake of Aβ is more efficient when TREM2 forms complexes with lipoproteins such as ApoE or CLU [132, 150] and TREM2–lipoprotein interaction is impaired by R47H and R62H mutations [3, 4].”
BackgroundInfluentialTheodosiou, M., Widmaier, M., Böttcher, R. T., Rognoni, E., Veelders, M., Bharadwaj, M., Lambacher, A., Austen, K., Müller, D. J., Zent, R., et al. (2016) · eLife · doi:10.7554/elife.10130 · Cited by 279
CAKβ/Pyk2 Kinase Is a Signaling Link for Induction of Long-Term Potentiation in CA1 Hippocampus
Huang, Y.-Q., Lu, W.-Y., Ali, D. W., Pelkey, K. A., Pitcher, G. M., Lu, Y. M., Aoto, H., Roder, J. C., Sasaki, T., Salter, M. W., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00220-3 · Cited by 274
Frandemiche, M. L., De Seranno, S., Rush, T., Borel, E., Elie, A., Arnal, I., Lanté, F., & Buisson, A. (2014) · The Journal of Neuroscience · doi:10.1523/jneurosci.4261-13.2014 · Cited by 272 · cited 1×
“Aβ exposure modifies Tau’s phosphorylation status and prevents it from relocalizing away from the post-synaptic domain following synaptic activation [29].”
BackgroundMondragón-Rodríguez, S., Trillaud-Doppia, E., Dudilot, A., Bourgeois, C., Lauzon, M., Leclerc, N., & Boehm, J. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.401240 · Cited by 272
Loss of Bin1 Promotes the Propagation of Tau Pathology
Calafate, S., Flavin, W., Verstreken, P., & Moechars, D. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.09.063 · Cited by 265
Bis, J. C., Jian, X., Kunkle, B. W., Chen, Y., Hamilton-Nelson, K. L., Bush, W. S., Salerno, W. J., Lancour, D., Ma, Y., Renton, A. E., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-018-0112-7 · Cited by 248 · cited 3×
“Finally, the Alzheimer’s disease sequencing project (ADSP) recently published its first results based on whole exome sequencing analysis, encompassing more than 5000 AD cases and controls, and reported two new candidate genes, IGHG3 and ZNF655 (Suppl.”
BackgroundSelf-citationWang, Z., Wang, B., Yang, L., Guo, Q., Aithmitti, N., Songyang, Z., & Zheng, H. (2009) · The Journal of Neuroscience · doi:10.1523/jneurosci.2132-09.2009 · Cited by 242
Sabo, S. L., Ikin, A. F., Buxbaum, J. D., & Greengard, P. (2001) · The Journal of Cell Biology · doi:10.1083/jcb.153.7.1403 · Cited by 237
Morris, G. P., Clark, I. A., Zinn, R., & Vissel, B. (2013) · Neurobiology of Learning and Memory · doi:10.1016/j.nlm.2013.07.002 · Cited by 236
Assessment of the genetic variance of late-onset Alzheimer's disease
Ridge, P. G., Hoyt, K. B., Boehme, K., Mukherjee, S., Crane, P. K., Haines, J. L., Mayeux, R., Farrer, L. A., Pericak-Vance, M. A., Schellenberg, G. D., et al. (2016) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2016.02.024 · Cited by 236
Tian, Y., Chang, J. C., Fan, E. Y., Flajolet, M., & Greengard, P. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1315110110 · Cited by 233 · cited 1×
“Alternatively, PICALM has been proposed to participate in the APP-CTF degradation through autophagy [135].”
BackgroundWilliamson, R., Scales, T., Clark, B. R., Gibb, G., Reynolds, C. H., Kellie, S., Bird, I. N., Varndell, I. M., Sheppard, P. W., Everall, I., et al. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-01-00010.2002 · Cited by 227 · cited 1×
“More specifically, rapid tyrosine phosphorylation of neuronal proteins including Tau and FAK can be observed in response to Aβ exposure involving Src family kinases [143].”
BackgroundClusterin regulates β-amyloid toxicity via Dickkopf-1-driven induction of the wnt–PCP–JNK pathway
Killick, R., Ribe, E. M., Al-Shawi, R., Malik, B., Hooper, C., Fernandes, C., Dobson, R., Nolan, P. M., Lourdusamy, A., Furney, S., et al. (2014) · Molecular Psychiatry · doi:10.1038/mp.2012.163 · Cited by 222 · cited 1×
“CLU has also been associated with the regulation of Aβ toxicity, where its knockdown leads to reduced toxicity through the involvement of Wnt-PCPJNK pathway [70].”
BackgroundGoedert, M., & Spillantini, M. G. (2017) · Molecular Brain · doi:10.1186/s13041-017-0298-7 · Cited by 213 · cited 1×
“A synapse-centred hypothesis also does not preclude the spreading hypothesis [34, 66], which could be either a downstream pathological event or a potential trigger”
BackgroundYoung-Pearse, T. L., Chen, A. C., Chang, R., Marquez, C., & Selkoe, D. J. (2008) · Neural Development · doi:10.1186/1749-8104-3-15 · Cited by 210 · cited 1×
“Accordingly, APP–integrin interaction is required for neurite outgrowth and contact guidance [123, 153].”
BackgroundThe Role of APP Processing and Trafficking Pathways in the Formation of Amyloid β‐Proteina
SELKOE, D. J., YAMAZAKI, T., CITRON, M., PODLISNY, M. B., KOO, E. H., TEPLOW, D. B., & HAASS, C. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34401.x · Cited by 205
Convergent genetic and expression data implicate immunity in Alzheimer's disease
International Genomics of Alzheimer's Disease Consortium (IGAP), Jones, L., Lambert, J., Wang, L., Choi, S., Harold, D., Vedernikov, A., Escott‐Price, V., Stone, T., Richards, A., et al. (2015) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2014.05.1757 · Cited by 199 · cited 1×
“Indeed, several genomic analyses suggest the involvement of microglia in AD: (1) the first reports on pathway enrichment analyses indicated the involvement of innate immunity in AD [81]; (2) as previously mentioned, these analyses highlighted the regulation of endocytosis (which is essential for phagocytosis) [64, 81]…”
BackgroundSelf-citationXiao, Q., Gil, S.-C., Yan, P., Wang, Y., Han, S., Gonzales, E., Perez, R., Cirrito, J. R., & Lee, J.-M. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.338376 · Cited by 194 · cited 2×
“As opposed to BIN1 and CD2AP, PICALM knockdown and overexpression, respectively, decreased and increased amyloid plaque loads in the hippocampi of 6-month-old APP/ PS1 mice [148].”
BackgroundAmyloid precursor protein (APP) regulates synaptic structure and function
Tyan, S.-H., Shih, A. Y.-J., Walsh, J. J., Maruyama, H., Sarsoza, F., Ku, L., Eggert, S., Hof, P. R., Koo, E. H., & Dickstein, D. L. (2012) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2012.07.009 · Cited by 191 · cited 1×
“Thirty-five percent decrease in spine density has been observed in neurons derived from APP−/− mice, which was partially rescued by sAPP-α conditioned medium [136].”
BackgroundTerwel, D., Steffensen, K. R., Verghese, P. B., Kummer, M. P., Gustafsson, J.-Å., Holtzman, D. M., & Heneka, M. T. (2011) · The Journal of Neuroscience · doi:10.1523/jneurosci.6546-10.2011 · Cited by 190
Amphiphysin 2 (BIN1) in physiology and diseases
Prokic, I., Cowling, B. S., & Laporte, J. (2014) · Journal of Molecular Medicine · doi:10.1007/s00109-014-1138-1 · Cited by 188
Actin dynamics and cofilin‐actin rods in alzheimer disease
Bamburg, J. R., & Bernstein, B. W. (2016) · Cytoskeleton · doi:10.1002/cm.21282 · Cited by 181 · cited 1×
“Formation of cofilin–actin rods in distal dendrites is detrimental for synapses [7, 19] and cofilin–actin rod pathology has been observed in the brains of post-mortem AD patients [101] and in animal models of AD [7].”
BackgroundPeripheral clearance of amyloid β peptide by complement C3-dependent adherence to erythrocytes
Rogers, J., Li, R., Mastroeni, D., Grover, A., Leonard, B., Ahern, G., Cao, P., Kolody, H., Vedders, L., Kolb, W. P., et al. (2006) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2005.09.043 · Cited by 175 · cited 1×
“Finally, a peripheral Aβ clearance mechanism involving CR1 in human erythrocytes has been proposed to be impaired in AD cases [105].”
BackgroundGenetics of Alzheimer's disease: new evidences for an old hypothesis?
Lambert, J., & Amouyel, P. (2011) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2011.02.002 · Cited by 171
Self-citationActin Out: Regulation of the Synaptic Cytoskeleton
Spence, E. F., & Soderling, S. H. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.r115.655118 · Cited by 171 · cited 1×
“, cortactin, profilin, drebrin or cofilin, and controls the shape of the dendritic spine [125].”
BackgroundShulman, J. M., Imboywa, S., Giagtzoglou, N., Powers, M. P., Hu, Y., Devenport, D., Chipendo, P., Chibnik, L. B., Diamond, A., Perrimon, N., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt478 · Cited by 167 · cited 2×
“TLN2 is a cytoplasmic adapter protein essential for integrin-mediated cell adhesion to the extracellular matrix [35].”
BackgroundCaglayan, S., Takagi-Niidome, S., Liao, F., Carlo, A.-S., Schmidt, V., Burgert, T., Kitago, Y., Füchtbauer, E.-M., Füchtbauer, A., Holtzman, D. M., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007747 · Cited by 166
Bellenguez, C., Charbonnier, C., Grenier-Boley, B., Quenez, O., Le Guennec, K., Nicolas, G., Chauhan, G., Wallon, D., Rousseau, S., Richard, A. C., et al. (2017) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2017.07.001 · Cited by 166 · cited 1×
“In addition, these methodologies demonstrated that both SORL1 and ABCA7 genes— already detected by GWAS—carried numerous loss-offunction variants leading to strong increases in AD risk [9, 98, 128].”
Self-citationTai, L. M., Ghura, S., Koster, K. P., Liakaite, V., Maienschein‐Cline, M., Kanabar, P., Collins, N., Ben‐Aissa, M., Lei, A. Z., Bahroos, N., et al. (2015) · Journal of Neurochemistry · doi:10.1111/jnc.13072 · Cited by 165
Bin1 and CD2AP polarise the endocytic generation of beta‐amyloid
Ubelmann, F., Burrinha, T., Salavessa, L., Gomes, R., Ferreira, C., Moreno, N., & Guimas Almeida, C. (2017) · The EMBO Reports · doi:10.15252/embr.201642738 · Cited by 165
CMS: An adapter molecule involved in cytoskeletal rearrangements
Kirsch, K. H., Georgescu, M.-M., Ishimaru, S., & Hanafusa, H. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.11.6211 · Cited by 162
Implication of the Immune System in Alzheimer's Disease: Evidence from Genome-Wide Pathway Analysis
Lambert, J.-C., Grenier-Boley, B., Chouraki, V., Heath, S., Zelenika, D., Fievet, N., Hannequin, D., Pasquier, F., Hanon, O., Brice, A., et al. (2010) · Journal of Alzheimer's Disease · doi:10.3233/jad-2010-100018 · Cited by 144 · cited 1×
“Indeed, several genomic analyses suggest the involvement of microglia in AD: (1) the first reports on pathway enrichment analyses indicated the involvement of innate immunity in AD [81]; (2) as previously mentioned, these analyses highlighted the regulation of endocytosis (which is essential for phagocytosis) [64, 81]…”
BackgroundSelf-citationTackenberg, C., Grinschgl, S., Trutzel, A., Santuccione, A. C., Frey, M. C., Konietzko, U., Grimm, J., Brandt, R., & Nitsch, R. M. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.129 · Cited by 130
EADI consortium, G. C., Lambert, J.-C., Grenier-Boley, B., Harold, D., Zelenika, D., Chouraki, V, Kamatani, Y., Sleegers, K., Ikram, M. A., Hiltunen, M., et al. (2013) · Molecular Psychiatry · doi:10.1038/mp.2012.14 · Cited by 129 · cited 1×
“FRMD4A [142] FRMD4A FERM domain containing 4A, FERM domain-containing protein that regulates epithelial cell polarity - regulates Tau secretion in HEK293 cells and mature cortical neurones [283] - a homozygous mutation in FRMD4A results in a syndrome of congenital microcephaly, intellectual disability and dysmorphism…”
BackgroundSelf-citationATP-binding cassette transporter A7 (ABCA7) loss of function alters Alzheimer amyloid processing
Satoh, K., Abe-Dohmae, S., Yokoyama, S., St George-Hyslop, P., & Fraser, P. E. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.655076 · Cited by 128
The Role of SORL1 in Alzheimer’s Disease
Yin, R.-H., Yu, J.-T., & Tan, L. (2015) · Molecular Neurobiology · doi:10.1007/s12035-014-8742-5 · Cited by 126 · cited 1×
“SORL1 underexpression has also been associated with an increase in Aβ production by blocking the redirection of endocytosed APP to the trans-Golgi network, which reduces APP processing in endosomes [113, 144, 152].”
BackgroundMissense variant in TREML2 protects against Alzheimer's disease
Benitez, B. A., Jin, S. C., Guerreiro, R., Graham, R., Lord, J., Harold, D., Sims, R., Lambert, J.-C., Gibbs, J. R., Bras, J., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2013.12.010 · Cited by 123
Self-citationSorting receptor SORLA – a trafficking path to avoid Alzheimer disease
Willnow, T. E., & Andersen, O. M. (2013) · Journal of Cell Science · doi:10.1242/jcs.125393 · Cited by 121 · cited 1×
“SORL1 underexpression has also been associated with an increase in Aβ production by blocking the redirection of endocytosed APP to the trans-Golgi network, which reduces APP processing in endosomes [113, 144, 152].”
BackgroundDourlen, P., Fernandez-Gomez, F. J., Dupont, C., Grenier-Boley, B., Bellenguez, C., Obriot, H., Caillierez, R., Sottejeau, Y., Chapuis, J., Bretteville, A., et al. (2017) · Molecular Psychiatry · doi:10.1038/mp.2016.59 · Cited by 118 · cited 4×
“TLN2 is a cytoplasmic adapter protein essential for integrin-mediated cell adhesion to the extracellular matrix [35].”
BackgroundInfluentialSelf-citationGSK-3 Is Activated by the Tyrosine Kinase Pyk2 during LPA1-mediated Neurite Retraction
Sayas, C. L., Ariaens, A., Ponsioen, B., & Moolenaar, W. H. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e05-07-0688 · Cited by 115
Grace, E. A., & Busciglio, J. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-02-00493.2003 · Cited by 113 · cited 2×
“In addition, aberrant activation of the FA pathway may mediate Aβ fibril-induced neuronal dystrophy [36].”
BackgroundHe, X., Cooley, K., Chung, C. H. Y., Dashti, N., & Tang, J. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.3993-06.2007 · Cited by 107
Kindlin-2 directly binds actin and regulates integrin outside-in signaling
Bledzka, K., Bialkowska, K., Sossey-Alaoui, K., Vaynberg, J., Pluskota, E., Qin, J., & Plow, E. F. (2016) · Journal of Cell Biology · doi:10.1083/jcb.201501006 · Cited by 107
Focal adhesions regulate Aβ signaling and cell death in Alzheimer's disease
Caltagarone, J., Jing, Z., & Bowser, R. (2007) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2006.11.007 · Cited by 102 · cited 1×
“FAs have also been established as regulators of Aβ signalling [15]; however, the mechanistic details of the regulatory mechanisms are poorly understood, as are their potential links to the genetic component of the AD.”
BackgroundGiralt, A., Brito, V., Chevy, Q., Simonnet, C., Otsu, Y., Cifuentes-Díaz, C., de Pins, B., Coura, R., Alberch, J., Ginés, S., et al. (2017) · Nature Communications · doi:10.1038/ncomms15592 · Cited by 102 · cited 1×
“Normalizing PTK2B levels rescues memory deficits, spines pathology and PSD-95 localization [72] - Role in the survival of cerebellar granule neurons [242] - Essential for astrocytes mobility following brain lesion [73]”
BackgroundWoo, J. A., Zhao, X., Khan, H., Penn, C., Wang, X., Joly-Amado, A., Weeber, E., Morgan, D., & Kang, D. E. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2015.5 · Cited by 99 · cited 1×
“Together, these results implicate the integrin–cofilin pathway to be critical in synaptic dysfunction in AD [36, 147].”
BackgroundZhao, Y., Tseng, I.-C., Heyser, C. J., Rockenstein, E., Mante, M., Adame, A., Zheng, Q., Huang, T., Wang, X., Arslan, P. E., et al. (2015) · Neuron · doi:10.1016/j.neuron.2015.08.020 · Cited by 98 · cited 1×
“Interestingly, several recent studies suggest that Tau may directly regulate synaptic function and plasticity: in healthy neurons, Tau is observed in the dendritic shaft as well as in pre- and post-synaptic structures [92, 94, 156].”
BackgroundSottejeau, Y., Bretteville, A., Cantrelle, F.-X., Malmanche, N., Demiaute, F., Mendes, T., Delay, C., Alves Dos Alves, H., Flaig, A., Davies, P., et al. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0237-8 · Cited by 98 · cited 1×
“Furthermore, human BIN1 directly binds Tau and this interaction in neurons depends on the level of BIN1 expression, as well as the phosphorylation statuses of both BIN1 and Tau [85, 89, 110, 124].”
BackgroundSelf-citationBIN1 regulates BACE1 intracellular trafficking and amyloid-β production
Miyagawa, T., Ebinuma, I., Morohashi, Y., Hori, Y., Young Chang, M., Hattori, H., Maehara, T., Yokoshima, S., Fukuyama, T., Tsuji, S., et al. (2016) · Human Molecular Genetics · doi:10.1093/hmg/ddw146 · Cited by 95 · cited 1×
“BIN1 depletion was associated with an increase in intracellular Aβ42, potentially through the regulation of the β-secretase (BACE1) trafficking and accumulation in early endosomes [91, 137].”
BackgroundCichon, J., Sun, C., Chen, B., Jiang, M., Chen, X. A., Sun, Y., Wang, Y., & Chen, G. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.301911 · Cited by 95 · cited 1×
“Formation of cofilin–actin rods in distal dendrites is detrimental for synapses [7, 19] and cofilin–actin rod pathology has been observed in the brains of post-mortem AD patients [101] and in animal models of AD [7].”
BackgroundGibbons, G. S., Banks, R. A., Kim, B., Changolkar, L., Riddle, D. M., Leight, S. N., Irwin, D. J., Trojanowski, J. Q., & Lee, V. M. Y. (2018) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/nly010 · Cited by 94 · cited 1×
“One can argue that spreading of an AD-specific Tau strain [32] may be involved in one of the entry points of the vicious cycle, leading to synaptic failure.”
BackgroundThe tale of two talins – two isoforms to fine‐tune integrin signalling
Gough, R. E., & Goult, B. T. (2018) · FEBS Letters · doi:10.1002/1873-3468.13081 · Cited by 93
The role of kindlins in cell biology and relevance to human disease
Lai-Cheong, J. E., Parsons, M., & McGrath, J. A. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2009.10.015 · Cited by 92
Genetic heterogeneity of Alzheimer's disease: Complexity and advances
Lambert, J., & Amouyel, P. (2007) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2007.05.015 · Cited by 87
Self-citationKlevanski, M., Herrmann, U., Weyer, S. W., Fol, R., Cartier, N., Wolfer, D. P., Caldwell, J. H., Korte, M., & Müller, U. C. (2015) · The Journal of Neuroscience · doi:10.1523/jneurosci.2009-15.2015 · Cited by 83
Alzheimer's Disease Risk Factor Pyk2 Mediates Amyloid-β-Induced Synaptic Dysfunction and Loss
Salazar, S. V., Cox, T. O., Lee, S., Brody, A. H., Chyung, A. S., Haas, L. T., & Strittmatter, S. M. (2019) · The Journal of Neuroscience · doi:10.1523/jneurosci.1873-18.2018 · Cited by 77 · cited 2×
“On hippocampal slices, Pyk2 is not required for basal synaptic transmission or long term potentiation but participates in long term depression [215] - Deficiency in mice have alterations in NMDA, PSD-95 and spines structures.”
BackgroundQuantitative modelling of amyloidogenic processing and its influence by SORLA in Alzheimer's disease
Schmidt, V., Baum, K., Lao, A., Rateitschak, K., Schmitz, Y., Teichmann, A., Wiesner, B., Petersen, C. M., Nykjaer, A., Wolf, J., et al. (2012) · The EMBO Journal · doi:10.1038/emboj.2011.352 · Cited by 75
Haas, L. T., & Strittmatter, S. M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.720664 · Cited by 75
ADGC, A. D. N. I., Chapuis, J., Flaig, A., Grenier-Boley, B., Eysert, F., Pottiez, V., Deloison, G., Vandeputte, A., Ayral, A.-M., Mendes, T., et al. (2017) · Acta Neuropathologica · doi:10.1007/s00401-016-1652-z · Cited by 75 · cited 3×
“Importantly, high-content screening also identified numerous FA pathway members—including Kindlin-2—as modulators of APP metabolism, highlighting the relevance of the core FA proteins to the AD process [17].”
BackgroundSelf-citationSartori, M., Mendes, T., Desai, S., Lasorsa, A., Herledan, A., Malmanche, N., Mäkinen, P., Marttinen, M., Malki, I., Chapuis, J., et al. (2018) · doi:10.1101/462317 · Cited by 72
Self-citationSartori, M., Mendes, T., Desai, S., Lasorsa, A., Herledan, A., Malmanche, N., Mäkinen, P., Marttinen, M., Malki, I., Chapuis, J., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-019-02017-9 · Cited by 72 · cited 2×
“Furthermore, human BIN1 directly binds Tau and this interaction in neurons depends on the level of BIN1 expression, as well as the phosphorylation statuses of both BIN1 and Tau [85, 89, 110, 124].”
BackgroundSelf-citationD’Alessandro, M., Hnia, K., Gache, V., Koch, C., Gavriilidis, C., Rodriguez, D., Nicot, A.-S., Romero, N. B., Schwab, Y., Gomes, E., et al. (2015) · Developmental Cell · doi:10.1016/j.devcel.2015.09.018 · Cited by 71
Pivotal role of the RanBP9-cofilin pathway in Aβ-induced apoptosis and neurodegeneration
Woo, J. A., Jung, A. R., Lakshmana, M. K., Bedrossian, A., Lim, Y., Bu, J. H., Park, S. A., Koo, E. H., Mook-Jung, I., & Kang, D. E. (2012) · Cell Death & Differentiation · doi:10.1038/cdd.2012.14 · Cited by 69 · cited 1×
“It has been also proposed that the scaffolding protein RanBP9, which exhibits an overall increase in AD brains, simultaneously promotes Aβ generation and FA disruption by accelerating APP and β1-integrin endocytosis [145].”
Johnson, R. I., Seppa, M. J., & Cagan, R. L. (2008) · The Journal of Cell Biology · doi:10.1083/jcb.200706108 · Cited by 67 · cited 2×
“CD2AP is involved in cell–cell adhesion, regulates the actin cytoskeleton and physically interacts with p130CAS (CASS1) [61, 74].”
BackgroundSorting receptor SORLA: cellular mechanisms and implications for disease
Schmidt, V., Subkhangulova, A., & Willnow, T. E. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2410-z · Cited by 65
Walter, S., Jumpertz, T., Hüttenrauch, M., Ogorek, I., Gerber, H., Storck, S. E., Zampar, S., Dimitrov, M., Lehmann, S., Lepka, K., et al. (2019) · Acta Neuropathologica · doi:10.1007/s00401-018-1929-5 · Cited by 65
Cofilin Rods and Aggregates Concur with Tau Pathology and the Development of Alzheimer's Disease
Rahman, T., Davies, D. S., Tannenberg, R. K., Fok, S., Shepherd, C., Dodd, P. R., Cullen, K. M., & Goldsbury, C. (2014) · Journal of Alzheimer’s Disease · doi:10.3233/jad-140393 · Cited by 63
Genome-wide association interaction analysis for Alzheimer's disease
Gusareva, E. S., Carrasquillo, M. M., Bellenguez, C., Cuyvers, E., Colon, S., Graff-Radford, N. R., Petersen, R. C., Dickson, D. W., Mahachie John, J. M., Bessonov, K., et al. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.05.014 · Cited by 63
Self-citationStructural Basis of Tau Interaction With BIN1 and Regulation by Tau Phosphorylation
Lasorsa, A., Malki, I., Cantrelle, F.-X., Merzougui, H., Boll, E., Lambert, J.-C., & Landrieu, I. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00421 · Cited by 58 · cited 1×
“Furthermore, human BIN1 directly binds Tau and this interaction in neurons depends on the level of BIN1 expression, as well as the phosphorylation statuses of both BIN1 and Tau [85, 89, 110, 124].”
BackgroundSelf-citationThe Emerging Role of Mechanics in Synapse Formation and Plasticity
Kilinc, D. (2018) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2018.00483 · Cited by 58
Self-citationProline-Rich Tyrosine Kinase 2 Regulates Hippocampal Long-Term Depression
Hsin, H., Kim, M. J., Wang, C.-F., & Sheng, M. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.1029-10.2010 · Cited by 55 · cited 2×
“Post-synaptic Tau has been demonstrated to be crucial for LTD [73].”
BackgroundThomas, R. S., Henson, A., Gerrish, A., Jones, L., Williams, J., & Kidd, E. J. (2016) · BMC Neuroscience · doi:10.1186/s12868-016-0288-1 · Cited by 55
Andrew, R. J., De Rossi, P., Nguyen, P., Kowalski, H. R., Recupero, A. J., Guerbette, T., Krause, S. V., Rice, R. C., Laury-Kleintop, L., Wagner, S. L., et al. (2019) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006379 · Cited by 55
Malki, I., Cantrelle, F., Sottejeau, Y., Lippens, G., Lambert, J., & Landrieu, I. (2017) · The FEBS Journal · doi:10.1111/febs.14185 · Cited by 54
Self-citationBeyond pathology: APP, brain development and Alzheimer's disease
Soldano, A., & Hassan, B. A. (2014) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2014.02.003 · Cited by 54 · cited 1×
“During development, APP is enriched in axonal growth cones and acts as a co-receptor for guidance cues through its interaction with the extracellular matrix [122, 123].”
BackgroundAmyloid Precursor Protein Is an Autonomous Growth Cone Adhesion Molecule Engaged in Contact Guidance
Sosa, L. J., Bergman, J., Estrada-Bernal, A., Glorioso, T. J., Kittelson, J. M., & Pfenninger, K. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064521 · Cited by 53 · cited 2×
“Accordingly, APP–integrin interaction is required for neurite outgrowth and contact guidance [123, 153].”
BackgroundShedding of APP limits its synaptogenic activity and cell adhesion properties
Stahl, R., Schilling, S., Soba, P., Rupp, C., Hartmann, T., Wagner, K., Merdes, G., Eggert, S., & Kins, S. (2014) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2014.00410 · Cited by 53
Liao, F., Jiang, H., Srivatsan, S., Xiao, Q., Lefton, K. B., Yamada, K., Mahan, T. E., Lee, J.-M., Shaw, A. S., & Holtzman, D. M. (2015) · Molecular Neurodegeneration · doi:10.1186/s13024-015-0006-y · Cited by 53 · cited 1×
“However, despite these effects on Aβ production in vitro, deleting a single BIN1 or CD2AP allele did not modify amyloid deposition in mouse models of AD [2, 87].”
BackgroundPyk2 is a Novel Tau Tyrosine Kinase that is Regulated by the Tyrosine Kinase Fyn
Li, C., & Götz, J. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180054 · Cited by 52 · cited 1×
“In addition, being a tyrosine kinase, Pyk2 has been shown to directly phosphorylate Tau [86].”
BackgroundBin1 directly remodels actin dynamics through its BAR domain
Dräger, N. M., Nachman, E., Winterhoff, M., Brühmann, S., Shah, P., Katsinelos, T., Boulant, S., Teleman, A. A., Faix, J., & Jahn, T. R. (2017) · The EMBO Reports · doi:10.15252/embr.201744137 · Cited by 51
Beck, T. N., Nicolas, E., Kopp, M. C., & Golemis, E. A. (2014) · Oncoscience · doi:10.18632/oncoscience.64 · Cited by 50
Lamartinière, Y., Boucau, M.-C., Dehouck, L., Krohn, M., Pahnke, J., Candela, P., Gosselet, F., & Fenart, L. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-170883 · Cited by 50
Pivotal role of RanBP9 in integrin‐dependent focal adhesion signaling and assembly
Woo, J. A., Roh, S., Lakshmana, M. K., & Kang, D. E. (2012) · The FASEB Journal · doi:10.1096/fj.11-194423 · Cited by 45 · cited 1×
“RanBP9 activates/ dephosphorylates cofilin, a key regulator of actin dynamics [146].”
BackgroundQu, H., Tu, Y., Guan, J.-L., Xiao, G., & Wu, C. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.580811 · Cited by 43
αv integrins mediate beta-amyloid induced inhibition of long-term potentiation
Wang, Q., Klyubin, I., Wright, S., Griswold-Prenner, I., Rowan, M. J., & Anwyl, R. (2008) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2007.03.018 · Cited by 42
Canobbio, I., Cipolla, L., Guidetti, G. F., Manganaro, D., Visconte, C., Kim, S., Okigaki, M., Falasca, M., Kunapuli, S. P., & Torti, M. (2015) · Biochemical Journal · doi:10.1042/bj20150048 · Cited by 40
Mukherjee, S., Russell, J. C., Carr, D. T., Burgess, J. D., Allen, M., Serie, D. J., Boehme, K. L., Kauwe, J. S. K., Naj, A. C., Fardo, D. W., et al. (2017) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2017.01.016 · Cited by 39
Aberrant accrual of BIN1 near Alzheimer’s disease amyloid deposits in transgenic models
Rossi, P. D., Andrew, R. J., Musial, T. F., Buggia-Prévot, V., Xu, G. M., Ponnusamy, M., Ly, H., Krause, S. V., Rice, R. C., de l’Estoile, V., et al. (2018) · Brain Pathology · doi:10.1111/bpa.12687 · Cited by 38
Yi, J. H., Brown, C., Whitehead, G., Piers, T., Lee, Y. S., Perez, C. M., Regan, P., Whitcomb, D. J., & Cho, K. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.04.015 · Cited by 36 · cited 1×
“Importantly, Tau’s role in regulating synapses does not appear to be redundant or functionally compensated in Tau knockout mice, suggesting a physiological role for Tau in synapses [151].”
BackgroundJones, A. V., Lambert, D. W., Speight, P. M., & Whawell, S. A. (2013) · FEBS Letters · doi:10.1016/j.febslet.2013.09.010 · Cited by 35
Siney, E. J., Holden, A., Casselden, E., Bulstrode, H., Thomas, G. J., & Willaime-Morawek, S. (2017) · Molecular Neurobiology · doi:10.1007/s12035-016-0053-6 · Cited by 35 · cited 1×
“Finally, the α-secretase ADAM10 has been functionally associated with several integrins [62, 121].”
BackgroundKunkle, B., Grenier-Boley, B., Sims, R., Bis, J., Naj, A., Boland, A., Vronskaya, M., van der Lee, S., Amlie-Wolf, A., Bellenguez, C., et al. (2018) · doi:10.1101/294629 · Cited by 35
Self-citationMale-specific epistasis between WWC1 and TLN2 genes is associated with Alzheimer's disease
Gusareva, E. S., Twizere, J.-C., Sleegers, K., Dourlen, P., Abisambra, J. F., Meier, S., Cloyd, R., Weiss, B., Dermaut, B., Bessonov, K., et al. (2018) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2018.08.001 · Cited by 32 · cited 2×
“TLN2 is a cytoplasmic adapter protein essential for integrin-mediated cell adhesion to the extracellular matrix [35].”
BackgroundSelf-citationEffects of apoE on neuronal signaling and APP processing in rodent brain
Hoe, H.-S., Pocivavsek, A., Dai, H., Chakraborty, G., Harris, D. C., & Rebeck, G. W. (2006) · Brain Research · doi:10.1016/j.brainres.2006.07.035 · Cited by 30
Specific interactions of neuronal focal adhesion kinase isoforms with Src kinases and amphiphysin
Messina, S., Onofri, F., Bongiorno‐Borbone, L., Giovedì, S., Valtorta, F., Girault, J., & Benfenati, F. (2003) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2003.01519.x · Cited by 26 · cited 12×
“As mentioned earlier, we were able to detect a genetic interaction between Pyk2 and Tau [26].”
BackgroundInfluentialFibrillar Aβ1-42 Enhances NMDA Receptor Sensitivity via the Integrin Signaling Pathway
Juhász, G., Barkóczi, B., Vass, G., Datki, Z., Hunya, Á. G., Fülöp, L., Budai, D., Penke, B., & Szegedi, V. (2010) · Journal of Alzheimer s Disease · doi:10.3233/jad-2010-1301 · Cited by 24
Han, H.-Y., Zhang, J.-P., Ji, S.-Q., Liang, Q.-M., Kang, H.-C., Tang, R.-H., Zhu, S.-Q., & Xue, Z. (2013) · PLoS ONE · doi:10.1371/journal.pone.0064839 · Cited by 20
Abnormal cleavage of APP impairs its functions in cell adhesion and migration
Sheng, B., Song, B., Zheng, Z., Zhou, F., Lu, G., Zhao, N., Zhang, X., & Gong, Y. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2008.11.046 · Cited by 20 · cited 1×
“, AICD, APPs-α) and impair APP function in cell adhesion and synaptic plasticity [117].”
BackgroundXu, Y.-X., Wang, H.-Q., Yan, J., Sun, X.-B., Guo, J.-C., & Zhu, C.-Q. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.09.022 · Cited by 15
Daudin, R., Marechal, D., Golgolab, R., Wang, Q., Abe, Y., Tsurugizawa, T., Bourg, N., Sartori, M., Loe-Mie, Y., Lipecka, J., et al. (2018) · doi:10.1101/437228 · Cited by 14 · cited 1×
“Finally, increased expression of BIN1 in mice has also been associated with alterations in dendritic spine density and in LTP dysregulation [22].”
BackgroundIdentification of Tau Toxicity Modifiers in the Drosophila Eye
Dourlen, P. (2016) · Methods in molecular biology · doi:10.1007/978-1-4939-6598-4_26 · Cited by 10
Self-citation
Research works printed but not linked: 2
- Guerreiro R, Wojtas A, Bras J, Carrasquillo M, Rogaeva E, Majounie E et al (2013) TREM2 variants in Alzheimer’s disease. N Engl J Med 368:117–127. https://doi.org/10.1056/nejmoa1211851 · DOI · Paper page
- Jones L, Lambert J-C, Wang L-S, Choi S-H, Harold D, Vedernikov A et al (2015) Convergent genetic and expression data implicate immunity in Alzheimer’s disease. Alzheimer’s Dement 11:658–671. https://doi.org/10.1016/j.jalz.2014.05.1757 · DOI · Paper page
Cited by
New insights into the genetic etiology of Alzheimer’s disease and related dementias
Bellenguez, C., Küçükali, F., Jansen, I. E., Kleineidam, L., Moreno-Grau, S., Amin, N., Naj, A. C., Campos-Martin, R., Grenier-Boley, B., Andrade, V., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01024-z · Cited by 2,498
Self-citationCellular functions of the protein kinase ATM and their relevance to human disease
Lee, J.-H., & Paull, T. T. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-021-00394-2 · Cited by 289
Mitochondrial Dysfunction as a Driver of Cognitive Impairment in Alzheimer’s Disease
Sharma, C., Kim, S., Nam, Y., Jung, U. J., & Kim, S. R. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094850 · Cited by 234
Genetics of Alzheimer’s disease: where we are, and where we are going
Bellenguez, C., Grenier-Boley, B., & Lambert, J.-C. (2020) · Current Opinion in Neurobiology · doi:10.1016/j.conb.2019.11.024 · Cited by 215
Self-citationDysfunctional Mitochondria and Mitophagy as Drivers of Alzheimer’s Disease Pathogenesis
Chakravorty, A., Jetto, C. T., & Manjithaya, R. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00311 · Cited by 219
Metadata
- Authors
- Dourlen, P., Kilinc, D., Malmanche, N., Chapuis, J., & Lambert, J.-C.
- Affiliations
- Inserm (FR)
- Corresponding author
- Lambert, Jean-Charles
- Venue
- Acta Neuropathologica
- Published
- 2019-04-13
- Volume
- 138
- Issue
- 2
- Pages
- 221-236
- ISSN
- 0001-6322 (ISSN-L)
- 1432-0533
- PMC
- PMC6660578
- OpenAlex
- W2936873828
- Cited by
- 168
- References
- 155
- Citations by year
- 2026: 4 · 2025: 19 · 2024: 11 · 2023: 14 · 2022: 35 · 2021: 40 · 2020: 30 · 2019: 15
- FWCI
- 3.53
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- Locations
- Acta Neuropathologica (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- LillOA (Université de Lille (University Of Lille)) (submittedVersion, other-oa)
- Funders
- Alzheimer's Association (BFG-14-318355)
- EU Joint Programme – Neurodegenerative Disease Research
- Development of Innovative Strategies for a Transdisciplinary approach to ALZheimer's disease
- Agence Nationale de la Recherche (ANR-11-LABX-0009, ANR-15-CE16-0002)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
- Keywords
- Alzheimer's disease, genetic risk factors, amyloid hypothesis, amyloid precursor protein, amyloid-beta, tau pathology, innate immunity, focal adhesion pathway, synaptic plasticity, genome-wide association study, pathogenesis
- MeSH terms
- Exome Sequencing, Alzheimer Disease, Amyloid, Animals, Disease Models, Animal, Endocytosis, Humans, Models, Genetic, Models, Neurological, Neuronal Plasticity, Risk Factors, Synapses, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, Neurofibrillary Tangles, tau Proteins, Genetic Predisposition to Disease, Focal Adhesions, Plaque, Amyloid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-11-02, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-11-02 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.